Imo A Ebong1, Pamela Schreiner, Cora E Lewis, Duke Appiah, Azmina Ghelani, Mellissa Wellons. 1. 1Division of Cardiology, University of Arizona College of Medicine, Tucson, AZ 2Department of Epidemiology, University of Minnesota, Minneapolis, MN 3Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL 4Department of Medicine, Loma Linda University Medical Center, Loma Linda, CA 5Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
Abstract
OBJECTIVE: The aim of this study was to determine the prevalence of hypertension in midlife women, characterize the association between high-sensitivity C-reactive protein (hs-CRP) and hypertension in women, and describe differences in hypertension prevalence by menopausal stage. METHODS: We included 1,625 women, aged 43 to 55 years, with measurements of hs-CRP and detailed reproductive histories in the Coronary Artery Risk Development in Young Adults study at follow-up year 25. Prevalent hypertension was defined as a systolic blood pressure of 140 mm Hg, or diastolic blood pressure of 90 mm Hg or greater, or use of antihypertensive medications. Logistic regression was used for analysis. RESULTS: The prevalence of hypertension was 25.8%, 37.8%, and 39.0% in premenopausal, perimenopausal, and postmenopausal women, respectively. The median (25th and 75th percentiles) of hs-CRP was 3.08 (1.12, 7.98) μg/mL and 1.18 (0.48, 3.15) μg/mL in women with and without hypertension, respectively. After adjusting for confounders, metabolic factors and body mass index, a doubling (100% increment) in hs-CRP levels was significantly associated with hypertension in premenopausal (1.27 [1.01-1.59]), but not in perimenopausal (1.12 [0.99-1.27]) or postmenopausal (1.09 [0.95-1.26]) women. CONCLUSIONS: Hypertension was common in midlife women. The association of hs-CRP and hypertension was consistent across menopausal stages. The association of hs-CRP with hypertension was independent of body mass index in premenopausal but not in perimenopausal or postmenopausal women.
OBJECTIVE: The aim of this study was to determine the prevalence of hypertension in midlife women, characterize the association between high-sensitivity C-reactive protein (hs-CRP) and hypertension in women, and describe differences in hypertension prevalence by menopausal stage. METHODS: We included 1,625 women, aged 43 to 55 years, with measurements of hs-CRP and detailed reproductive histories in the Coronary Artery Risk Development in Young Adults study at follow-up year 25. Prevalent hypertension was defined as a systolic blood pressure of 140 mm Hg, or diastolic blood pressure of 90 mm Hg or greater, or use of antihypertensive medications. Logistic regression was used for analysis. RESULTS: The prevalence of hypertension was 25.8%, 37.8%, and 39.0% in premenopausal, perimenopausal, and postmenopausal women, respectively. The median (25th and 75th percentiles) of hs-CRP was 3.08 (1.12, 7.98) μg/mL and 1.18 (0.48, 3.15) μg/mL in women with and without hypertension, respectively. After adjusting for confounders, metabolic factors and body mass index, a doubling (100% increment) in hs-CRP levels was significantly associated with hypertension in premenopausal (1.27 [1.01-1.59]), but not in perimenopausal (1.12 [0.99-1.27]) or postmenopausal (1.09 [0.95-1.26]) women. CONCLUSIONS: Hypertension was common in midlife women. The association of hs-CRP and hypertension was consistent across menopausal stages. The association of hs-CRP with hypertension was independent of body mass index in premenopausal but not in perimenopausal or postmenopausal women.
Authors: Lu Wang; Joann E Manson; J Michael Gaziano; Simin Liu; Barbara Cochrane; Nancy R Cook; Paul M Ridker; Nader Rifai; Howard D Sesso Journal: Clin Chem Date: 2011-03-11 Impact factor: 8.327
Authors: Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker Journal: JAMA Date: 2003-12-10 Impact factor: 56.272
Authors: Hilary K Whitham; Richard F Maclehose; Bernard L Harlow; Melissa F Wellons; Pamela J Schreiner Journal: Maturitas Date: 2013-05-22 Impact factor: 4.342
Authors: Lu Wang; Moyses Szklo; Aaron R Folsom; Nancy R Cook; Susan M Gapstur; Pamela Ouyang Journal: Atherosclerosis Date: 2012-07-20 Impact factor: 5.162
Authors: Shruti Dasgupta; Mohammed Salman; S Lokesh; D Xaviour; S Yaseen Saheb; B V Ravi Prasad; Biswanath Sarkar Journal: J Midlife Health Date: 2012-01
Authors: Erica P Gunderson; Vicky Chiang; Mark J Pletcher; David R Jacobs; Charles P Quesenberry; Stephen Sidney; Cora E Lewis Journal: J Am Heart Assoc Date: 2014-03-12 Impact factor: 6.106
Authors: Joshua A N van Apeldoorn; Eva L van der Linden; Silver Bahendeka; Erik Beune; Karlijn A C Meeks; Kerstin Klipstein-Grobusch; Bert-Jan van den Born; Charles Agyemang Journal: J Hypertens Date: 2022-02-01 Impact factor: 4.844
Authors: Jonathan J Ruiz-Ramie; Jacob L Barber; Donald M Lloyd-Jones; Myron D Gross; Jamal S Rana; Stephen Sidney; David R Jacobs; Abbi D Lane-Cordova; Mark A Sarzynski Journal: J Am Heart Assoc Date: 2021-08-21 Impact factor: 5.501